Watchman Device
A new option to reduce strokes in patients with Atrial Fibrillation (Afib)
We are proud to announce that Florida Cardiovascular Group’s team of cardiologists were the first in the state of Florida to implant the Watchman Device to prevent strokes in patients with Afib.
Patients with atrial fibrillation (Afib) have on average a 5 fold higher risk of having a stroke. Most strokes are caused by blood clots that originate in the left atrial appendage.
Traditionally, blood thinners have been used to reduce the risk of strokes in patients with Afib. However, these medications may cause side effects, and also increase the risk of bleeding.
The WATCHMAN™ LAAC Device offers a new stroke risk reduction option for patients with non-valvular atrial fibrillation who are seeking an alternative to long-term warfarin therapy.
WATCHMAN Animation
Please watch our presentation to learn more about Afib and the WATCHMAN™ LAAC Device.
Bill’s WATCHMAN Story
Patients with AFib have a five-fold increased risk of stroke due to blood stagnating from the improperly beating atrium and the resulting blood clot formation. This device is a potential alternative to long-term oral anti-coagulation to reduce the risk of stroke related to AFib.
Disclaimer: The WATCHMAN FLXT Left Atrial Appendage Closure Device is an investigational device and is not available for sale in the U.S. or Europe.
